Dana Stangel gave a presentation about patent protection for personalized medicine at the Precision Medicine Summit on July 29, 2016, in Loveland, Colorado. Precision medicine is a new approach to treating cancer and other diseases that aims to be less costly and more effective than traditional methods. It may be defined as providing the right patient with the right treatment at the right time.
In her presentation, Dana said there have been some "very significant changes" in patent protection for personalized medicine over the last five years. She discussed the evolving legal standard for patent eligibility in the context of new treatment methods, vaccines, therapeutic small molecules, and diagnostics.
Addressing another aspect of patent protection, Dr. Unsu Jung, Supervisory Patent Examiner at the U.S. Patent Office, spoke about the recently-announced Cancer Immunotherapy Pilot Program offering free fast-track review of qualifying patent applications to support the National Cancer Moonshot led by Vice President Biden.
The Summit addressed topics ranging from scientific developments to policy considerations and healthcare business models. Speakers included representatives of Biodesix, KromaTiD, UCHealth North, Catholic Health Initiatives, Colorado State University, and Innosphere.
Dana Stangel's presentation slides are viewable online and additional information about the 2016 Precision Medicine Summit is available in an article published by InnovatioNews.
Dana Stangel (right) and Dr. Unsu Jung (left) at the Precision Medicine Summit.